Home > News > Anti-cancer nanotechnology - a two-pronged attack
August 1st, 2005
Anti-cancer nanotechnology - a two-pronged attack
Richard Jones: Drug delivery - and in particular the delivery of anti-cancer therapeutics - has emerged as one of the major applications of nanotechnology in medicine. There’s a nice brief review of the subject by Ruth Duncan in this month’s issue of Nano Today: - Nanomedicine gets clinical . An interesting paper in this week’s Nature reports a significant new development from Sasisekharan’s group at MIT, in which two drugs are combined in a single delivery system. This nanovector first selectively targets tumour tissue, then releases a drug which cuts off the blood supply to the tumour, isolating and starving it, and then releases a second drug which directly attacks the tumour cells.
Nanion Technologies Appoints James Costantin as Director of Customer Relations: Nanion is pleased to announce the appointment of Dr. James Costantin as Director of Customer Relations at Nanion Technologies Inc. March 31st, 2015
Nanomedicine shines light on combined force of nanomedicine and regenerative medicine March 31st, 2015
Prototype 'nanoneedles' generate new blood vessels in mice: Scientists have developed tiny 'nanoneedles' that have successfully prompted parts of the body to generate new blood vessels, in a trial in mice March 31st, 2015
Nanomedicine pioneer Mauro Ferrari at ETH Zurich March 31st, 2015